Steve E. Krognes - Net Worth and Insider Trading

Steve E. Krognes Net Worth

The estimated net worth of Steve E. Krognes is at least $23 Million dollars as of 2024-11-05. Steve E. Krognes is the Director of Denali Therapeutics Inc and owns about 840,893 shares of Denali Therapeutics Inc (DNLI) stock worth over $23 Million. Details can be seen in Steve E. Krognes's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steve E. Krognes has not made any transactions after 2024-09-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Steve E. Krognes

To

Steve E. Krognes Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Steve E. Krognes owns 4 companies in total, including Denali Therapeutics Inc (DNLI) , Gritstone Bio Inc (GRTSQ) , and Corvus Pharmaceuticals Inc (CRVS) among others .

Click here to see the complete history of Steve E. Krognes’s form 4 insider trades.

Insider Ownership Summary of Steve E. Krognes

Ticker Comapny Transaction Date Type of Owner
DNLI Denali Therapeutics Inc 2024-09-30 CFO and Treasurer
GRTSQ Gritstone Bio Inc 2023-06-16 director
CRVS Corvus Pharmaceuticals Inc 2017-06-08 director
LIMIT LIMIT 2022-06-30 director

Steve E. Krognes Latest Holdings Summary

Steve E. Krognes currently owns a total of 1 stock. Steve E. Krognes owns 840,893 shares of Denali Therapeutics Inc (DNLI) as of September 30, 2024, with a value of $23 Million.

Latest Holdings of Steve E. Krognes

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DNLI Denali Therapeutics Inc 2024-09-30 840,893 27.21 22,880,699

Holding Weightings of Steve E. Krognes


Steve E. Krognes Form 4 Trading Tracker

According to the SEC Form 4 filings, Steve E. Krognes has made a total of 21 transactions in Denali Therapeutics Inc (DNLI) over the past 5 years, including 0 buys and 21 sells. The most-recent trade in Denali Therapeutics Inc is the sale of 30,000 shares on September 30, 2024, which brought Steve E. Krognes around $870,900.

Insider Trading History of Steve E. Krognes

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Steve E. Krognes Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Steve E. Krognes Ownership Network

Ownership Network List of Steve E. Krognes

No Data

Ownership Network Relation of Steve E. Krognes

Insider Network Chart

Steve E. Krognes Owned Company Details

What does Denali Therapeutics Inc do?

Who are the key executives at Denali Therapeutics Inc?

Steve E. Krognes is the CFO and Treasurer of Denali Therapeutics Inc. Other key executives at Denali Therapeutics Inc include director & President and CEO Ryan J. Watts , COO and Secretary Alexander O. Schuth , and Chief Medical Officer Carole Ho .

Denali Therapeutics Inc (DNLI) Insider Trades Summary

Over the past 18 months, Steve E. Krognes made 7 insider transaction in Denali Therapeutics Inc (DNLI) with a net sale of 162,292. Other recent insider transactions involving Denali Therapeutics Inc (DNLI) include a net sale of 25,506 shares made by Vicki L Sato , a net sale of 83,768 shares made by Alexander O. Schuth , and a net sale of 54,249 shares made by Carole Ho .

In summary, during the past 3 months, insiders sold 113,507 shares of Denali Therapeutics Inc (DNLI) in total and bought 0 shares, with a net sale of 113,507 shares. During the past 18 months, 459,258 shares of Denali Therapeutics Inc (DNLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 459,258 shares.

Denali Therapeutics Inc (DNLI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Denali Therapeutics Inc Insider Transactions

No Available Data

Steve E. Krognes Mailing Address

Above is the net worth, insider trading, and ownership report for Steve E. Krognes. You might contact Steve E. Krognes via mailing address: 863 Mitten Road, Suite 102, Burlingame Ca 94010.